rs867790304

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001009944.3(PKD1):​c.-195G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000758 in 216,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.00096 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00031 ( 0 hom. )

Consequence

PKD1
NM_001009944.3 5_prime_UTR

Scores

2

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.276

Publications

0 publications found
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
MIR3180-5 (HGNC:38969): (microRNA 3180-5) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 16-2135884-C-T is Benign according to our data. Variant chr16-2135884-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 433936.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000956 (143/149506) while in subpopulation SAS AF = 0.00456 (22/4824). AF 95% confidence interval is 0.00309. There are 0 homozygotes in GnomAd4. There are 72 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001009944.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD1
NM_001009944.3
MANE Select
c.-195G>A
5_prime_UTR
Exon 1 of 46NP_001009944.3P98161-1
PKD1
NM_000296.4
c.-195G>A
5_prime_UTR
Exon 1 of 46NP_000287.4
MIR3180-5
NR_037467.1
n.*93G>A
downstream_gene
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD1
ENST00000262304.9
TSL:1 MANE Select
c.-195G>A
5_prime_UTR
Exon 1 of 46ENSP00000262304.4P98161-1
PKD1
ENST00000423118.5
TSL:1
c.-195G>A
5_prime_UTR
Exon 1 of 46ENSP00000399501.1P98161-3
MIR3180-5
ENST00000583743.1
TSL:6
n.*93G>A
downstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.000957
AC:
143
AN:
149394
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000170
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00159
Gnomad ASJ
AF:
0.00116
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00456
Gnomad FIN
AF:
0.000631
Gnomad MID
AF:
0.0223
Gnomad NFE
AF:
0.00103
Gnomad OTH
AF:
0.00194
GnomAD4 exome
AF:
0.000315
AC:
21
AN:
66762
Hom.:
0
Cov.:
0
AF XY:
0.000442
AC XY:
14
AN XY:
31694
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000691
AC:
1
AN:
1448
American (AMR)
AF:
0.00
AC:
0
AN:
86
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
382
East Asian (EAS)
AF:
0.00
AC:
0
AN:
302
South Asian (SAS)
AF:
0.00150
AC:
2
AN:
1334
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
24
Middle Eastern (MID)
AF:
0.00781
AC:
1
AN:
128
European-Non Finnish (NFE)
AF:
0.000230
AC:
14
AN:
60984
Other (OTH)
AF:
0.00145
AC:
3
AN:
2074
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000000794552), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.368
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000956
AC:
143
AN:
149506
Hom.:
0
Cov.:
31
AF XY:
0.000986
AC XY:
72
AN XY:
73014
show subpopulations
African (AFR)
AF:
0.000170
AC:
7
AN:
41202
American (AMR)
AF:
0.00159
AC:
24
AN:
15068
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
4
AN:
3448
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5094
South Asian (SAS)
AF:
0.00456
AC:
22
AN:
4824
European-Finnish (FIN)
AF:
0.000631
AC:
6
AN:
9502
Middle Eastern (MID)
AF:
0.0240
AC:
7
AN:
292
European-Non Finnish (NFE)
AF:
0.00103
AC:
69
AN:
67084
Other (OTH)
AF:
0.00192
AC:
4
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000810
Hom.:
0
Bravo
AF:
0.00125

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Polycystic kidney disease (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
13
DANN
Benign
0.96
PhyloP100
0.28
PromoterAI
-0.031
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs867790304; hg19: chr16-2185885; API